Advanced company searchLink opens in new window

KELSO PHARMA LIMITED

Company number SC678102

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
20 Mar 2024 AA Accounts for a dormant company made up to 31 December 2023
09 Nov 2023 CS01 Confirmation statement made on 29 October 2023 with no updates
03 Feb 2023 AA Accounts for a dormant company made up to 31 December 2022
31 Oct 2022 CS01 Confirmation statement made on 29 October 2022 with updates
25 Apr 2022 AA Micro company accounts made up to 31 December 2021
02 Nov 2021 AA01 Current accounting period extended from 31 October 2021 to 31 December 2021
29 Oct 2021 CS01 Confirmation statement made on 29 October 2021 with updates
05 Mar 2021 PSC01 Notification of Andrew Firth Mclean as a person with significant control on 6 January 2021
05 Mar 2021 PSC01 Notification of Allan Mark Watson as a person with significant control on 6 January 2021
05 Mar 2021 PSC04 Change of details for Dr Harry Thomas Stratford as a person with significant control on 5 March 2021
07 Jan 2021 SH01 Statement of capital following an allotment of shares on 6 January 2021
  • GBP 3
07 Jan 2021 AP01 Appointment of Allan Mark Watson as a director on 6 January 2021
07 Jan 2021 AP01 Appointment of Mr Andrew Firth Mclean as a director on 6 January 2021
20 Oct 2020 NEWINC Incorporation
  • MODEL ARTICLES ‐ Model articles adopted

Statement of capital on 2020-10-20
  • GBP 1